MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2024-25)
- Udyam number
- UDYAM-MH-19-0005833
DWD Pharmaceuticals Limited - healthcare in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹166.47 Cr
▲ 10% YoY
Net profit · FY 2025
₹18.35 Cr
Net margin 11%
EBITDA · FY 2025
₹30.12 Cr
EBITDA margin 18.1%
Authorised capital
₹5 Cr
Registered with MCA
Paid-up capital
₹70 Lakh
Issued & subscribed
Open charges
₹1.8 Cr
Satisfied ₹16.63 Cr
Company age
59 yrs
Est. 1967
Employees · EPFO
1,150
Provident fund records
About DWD Pharmaceuticals Limited
Data last updated:
DWD Pharmaceuticals Limited is a public limited company based in Mumbai, Maharashtra, India. It operates in the medical equipment retail and distribution segment of the healthcare sector. It was incorporated on 08 May 1967 and has been in existence for over 59 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U25209MH1970PLC014700. Its GSTIN is 27AAACD9670L1Z6 (Maharashtra). The company holds 18 GST registrations, of which 14 are active.
The company has an authorised share capital of ₹5 Cr and a paid-up capital of ₹70 Lakh. It was formerly known as Plastichemical Projects Limited and Plastichemical Projects Private Limited. It is led by directors including Sachin Navinchandra Doshi (Whole-Time Director) and Meeta Samir Sheth.
Its last annual general meeting (AGM) was held on 29 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Dalamal House 4th Floor 206 Blackbay Reclmatn. Nariman Point, Mumbai, Maharashtra, India – 400021.
As per the financials filed for FY 2025, the company reported a revenue of ₹166.47 Cr, a growth of 10% compared to the previous year. For the same year it recorded a net profit of ₹18.35 Cr (net margin 11%) and EBITDA of ₹30.12 Cr (EBITDA margin 18.1%). Revenue has grown at a compounded annual rate (CAGR) of 12% over three years and 9% over five years.
The company has about 1,150 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: DWD Pharmaceuticals. As per MCA filings, the company has open charges of ₹1.8 Cr and satisfied charges of ₹16.63 Cr on record. Court records list 30 cases involving the company, including 20 filed by the company and 10 filed against it; 12 cases are pending. The company has 6 deals on record (5 secondary share transfers, 1 convertible or debt financing), with disclosed funding of ₹8 Cr; the latest was in August 2017. Its 7 peer companies in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 3 larger and 4 smaller; the largest is Eurolife Healthcare Private Limited with revenue of ₹168.9 Cr. The company has 12 MSME Form 1 returns on record between 2019 and 2024, listing 258 overdue payments to 56 micro and small suppliers.
DWD Pharmaceuticals Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-19-0005833). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website dwdindia.com.
Company details
CIN U25209MH1970PLC014700
Registration Number 014700
Incorporation Date 08 May 1967
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 29 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-MH-19-0005833
Name history
DWD Pharmaceuticals has undergone 2 name changes throughout its history. The company was previously known as Plastichemical Projects Limited, and Plastichemical Projects Private Limited. The current legal name is Dwd Pharmaceuticals Limited.
| Company Name | Status |
|---|---|
| DWD Pharmaceuticals Limited | Current |
| Plastichemical Projects Limited | Previous |
| Plastichemical Projects Private Limited | Previous |
Key People
Sachin Navinchandra Doshi Whole-Time Director Meeta Samir Sheth Director Kaushik Maniar Director Recognitions & Rankings of DWD Pharmaceuticals
Contact details
DWD Pharmaceuticals Limited's registered office is in Mumbai, Maharashtra. Its website is dwdindia.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressDalamal House 4th Floor 206 Blackbay Reclmatn. Nariman Point, Mumbai, Maharashtra, India – 400021
- IndustryHealthcare, Medical Equipment Retail & Distribution
To see the full contact details of DWD Pharmaceuticals Limited, buy the company report.
Comprehensive company report
DWD Pharmaceuticals Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
DWD Pharmaceuticals operates one associated brand: DWD Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical manufacturing and healthcare knowledge services in India. | dwdindia.com |
Business activity
The main business activities of DWD Pharmaceuticals are manufacturing and trade. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products and wholesale trading. 2 activity segments are registered with the MCA.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | |
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of DWD Pharmaceuticals Limited, buy the company report.
Financials of DWD Pharmaceuticals Limited
FY 2024 filings availableDWD Pharmaceuticals Limited reported revenue of ₹166.47 Cr (up 10% YoY) for FY 2025.
Revenue · FY 2025
₹166.47 Cr ▲ 10%
Net profit · FY 2025
₹18.35 Cr margin 11%
EBITDA · FY 2025
₹30.12 Cr margin 18.1%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 10%
3 years · compounded
▲ 12%
5 years · compounded
▲ 9%
EBITDA CAGR growth
1 year
▼ 8%
3 years · compounded
▲ 2%
5 years · compounded
▲ 4%
Revenue has grown at a compounded annual rate (CAGR) of 9% over five years, including 10% growth in the latest year. EBITDA fell 8% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹30.12 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹18.35 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 18.1% | ||||
| Net Profit Margin | 11% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of DWD Pharmaceuticals Limited, buy the company report.
Board of directors of DWD Pharmaceuticals Limited
DWD Pharmaceuticals has 4 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sachin Navinchandra Doshi Also directs: Adore Pharmaceuticals Pvt Ltd, Bezel Pharma Pvt Ltd, Noetic Finance Private Limited and 3 more | Whole-Time Director | 01 Apr 1996 | 30 Years 6 Months | Current |
| Meeta Samir Sheth | Director | 10 Nov 2017 | 8 Years 11 Months | Current |
| Kaushik Maniar | Director | 04 Sep 2020 | 6 Years 1 Months | Current |
| Niraj Anilkumar Mehta Also directs: Coral India Finance and Housing Limited, Ala Wealthmakers LLP, Ala Agropower Private Limited and 3 more | Director | 04 Sep 2020 | 6 Years 1 Months | Current |
Peer comparison
DWD Pharmaceuticals Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Eurolife Healthcare Private Limited | ₹168.9 Cr (FY 2020) | -20.0% | Thane, Maharashtra, India | |||
| Medicamen Biotech Limited | ₹168.79 Cr (FY 2025) | -7.0% | New Delhi, Delhi, India | |||
| Group Pharmaceuticals Limited | ₹168.31 Cr (FY 2025) | 10.0% | Thane, Maharashtra, India | |||
| DWD Pharmaceuticals Limitedthis company | ₹166.47 Cr (FY 2025) | ₹18.35 Cr | 11% | 10.0% | 1,150 | Mumbai, Maharashtra, India |
| Srini Pharmaceuticals Private Limited | ₹165.56 Cr (FY 2024) | -18.0% | Hyderabad, Telangana, India | |||
| Inject Care Parenterals Private Limited | ₹165.13 Cr (FY 2025) | 13.0% | Vapi, Gujarat, India | |||
| Time Cap Pharma Labs Private Limited | ₹165.03 Cr (FY 2025) | 477.0% | Hyderabad, Telangana, India | |||
| Deedy Chemicals Pvt Ltd | ₹163.89 Cr (FY 2025) | 22.0% | Ahmedabad, Gujarat, India |
To see the full peer comparison of DWD Pharmaceuticals Limited, buy the company report.
Auditor
DWD Pharmaceuticals Limited is audited by For Hasmukh Shah & Co LLP for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| For Hasmukh Shah & Co LLP | FY 2024 | 103592W/W100028 |
Shareholding
The shareholding of DWD Pharmaceuticals Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of DWD Pharmaceuticals Limited, buy the company report.
Charges & borrowings
Open charges
₹1.8 Cr
Satisfied charges
₹16.63 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 16 Feb 2023 | 100676625 | Hdfc Bank Limited | ₹1.8 Cr | Open | |
| 26 Mar 2021 | 100432604 | Standard Chartered Bank | ₹1 Cr | Satisfied | |
| 25 Feb 2020 | 100347025 | Others | ₹23.37 Lakh | Satisfied | |
| 04 May 2018 | 100174427 | Standard Chartered Bank | ₹7 Cr | Satisfied | |
| 15 Mar 2013 | 10416171 | Standard Chartered Bank | ₹8.4 Cr | Satisfied |
To see the full charge records of DWD Pharmaceuticals Limited, buy the company report.
Total charge records: 5 View all charges
Deals & funding
DWD Pharmaceuticals Limited has 6 deals on record (5 secondary share transfers, 1 convertible or debt financing), with disclosed funding of ₹8 Cr; the latest was in August 2017.
Total deals
6
Secondary share transfers
5
Convertible or debt financing
1
Disclosed funding
₹8 Cr
Deals on record (5 of 6)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Aug 2017 | Secondary share transfer | Undisclosed | Buyer: 3 individuals Seller: 3 individuals |
| May 2017 | Secondary share transfer | Undisclosed | Buyer: Noetic Finance Private Limited Seller: an individual |
| Feb 2017 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Mar 2016 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: Navin Doshi HUf |
| Nov 2013 | Secondary share transfer | Undisclosed | Buyer: 4 individuals Seller: 2 individuals |
To see the full deal history of DWD Pharmaceuticals Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
DWD Pharmaceuticals Limited has 30 court cases on record: 20 filed by DWD Pharmaceuticals, 10 filed against it. 12 cases are pending and 18 are disposed.
Total cases
30
Filed by the company
20
Filed against the company
10
Pending
12
Disposed
18
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 18 | 4 | 8 |
| District courts | 10 | 4 | 4 |
| Supreme Court | 1 | 1 | 0 |
| NCLT | 1 | 1 | 0 |
Cases on record (5 of 30)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Delhi | Court case (C.O. (COMM.IPD-TM)) | Filed by the company against Celsius Healthcare Pvt Ltd & Anr. | Pending |
| High Court of Delhi | Commercial suit | Filed by the company against Focaz Medipharma Pvt Ltd | Pending |
| High Court of Delhi | Commercial suit | Filed by the company against Celsius Healthcare Pvt Ltd | Pending |
| High Court of Delhi | Commercial suit | Filed by the company against Goodcare Pharma Pvt Ltd & Anr. | Pending |
| Bombay High Court | Court case (LPETN) | Filed by the company against Neel Nayan Pharma Pvt Ltd and 1 other | Pending |
To see the full case history of DWD Pharmaceuticals Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
DWD Pharmaceuticals Limited has 12 MSME Form 1 returns on record between 2019 and 2024, listing 258 overdue payments to 56 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 56)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Yacca Lifesciences Private Limited | |||
| Accutech Packaging Private Limited | |||
| an individual supplier | |||
| an individual supplier | |||
| Shree Goverdhan Packaging Industries |
To see the full MSME payment records of DWD Pharmaceuticals Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
DWD Pharmaceuticals Limited has a workforce of 1,150 employees on its EPFO records as of Mar 25, 2025, across 1 active EPFO establishment.
Employee count
1,150
Active EPFO establishments
1
Employee growth
16.63%
GST
DWD Pharmaceuticals has 18 GST registrations: 14 active and 4 cancelled or inactive. The first 4 active GSTINs are listed below.
Total GSTINs
18
Active
14
Cancelled / inactive
4
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAACD9670L1Z6 | Maharashtra | Active | 01 Jul 2017 |
| 08AAACD9670L1Z6 | Rajasthan | Active | 01 Jul 2017 |
| 09AAACD9670L1Z4 | Uttar Pradesh | Active | 01 Jul 2017 |
| 10AAACD9670L1ZL | Bihar | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of DWD Pharmaceuticals Limited, buy the company report.
Recent activity
DWD Pharmaceuticals Limited has 10 board changes on record since 1996: 4 appointments and 6 cessations. The latest: Sachin Navinchandra Doshi ceased to be Director on 01 Apr 2021.
AGM
Dwd Pharmaceuticals Limited last Annual general meeting of members was held on 29 Sep 2024 as per latest MCA records.
Filing
Dwd Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
Charges
A charge registered on 26 Mar 2021 via Charge ID 100432604 with Standard Chartered Bank was fully satisfied on 15 Jun 2023.
Charges
A charge with Standard Chartered Bank of Rs. 1.00 Cr registered on 26 Mar 2021 with Charge ID 100432604 was modified on 26 Apr 2023.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 1.80 Cr with Charge ID 100676625 was registered on 16 Feb 2023.
Ceased
Sachin Navinchandra Doshi ceased to be Director.
Charges
A charge with Standard Chartered Bank amounted to Rs. 1.00 Cr with Charge ID 100432604 was registered on 26 Mar 2021.
Charges
A charge registered on 04 May 2018 via Charge ID 100174427 with Standard Chartered Bank was fully satisfied on 18 Mar 2021.
Charges
A charge registered on 25 Feb 2020 via Charge ID 100347025 with Others was fully satisfied on 05 Mar 2021.
Ceased
Kaushik Maniar ceased to be Additional Director.
Ceased
Niraj Anilkumar Mehta ceased to be Additional Director.
Ceased
Jaswant Jagjibandas Mehta ceased to be Director.
11 earlier events are in the company report.
Frequently asked questions
DWD Pharmaceuticals is an active public limited company based in Mumbai, Maharashtra, India. The company works in medical equipment retail and distribution, within the healthcare industry. It was incorporated on 08 May 1967 (59+ years old) and is registered under CIN U25209MH1970PLC014700.
DWD Pharmaceuticals has 4 current directors:
- Sachin Navinchandra Doshi - Whole-Time Director
- Meeta Samir Sheth - Director
- Kaushik Maniar - Director
- Niraj Anilkumar Mehta - Director
The latest financial statements of DWD Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 29 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of DWD Pharmaceuticals is 27AAACD9670L1Z6, registered in Maharashtra. The company has 18 GST registrations in all, of which 14 are active and 4 are cancelled or inactive. Other active GSTINs include 08AAACD9670L1Z6 (Rajasthan), 09AAACD9670L1Z4 (Uttar Pradesh), 10AAACD9670L1ZL (Bihar).
The CIN (Corporate Identification Number) of DWD Pharmaceuticals is U25209MH1970PLC014700. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
DWD Pharmaceuticals has 30 court cases on record: 20 filed by the company and 10 filed against it. 12 are pending. Most are in the high courts.
DWD Pharmaceuticals was incorporated on 08 May 1967, making it 59+ years old. It is registered with the Registrar of Companies, Mumbai.
DWD Pharmaceuticals has 6 deals on record (5 secondary share transfers, 1 convertible or debt financing), with disclosed funding of ₹8 Cr; the latest was in August 2017.
The peers of DWD Pharmaceuticals by revenue are Eurolife Healthcare Private Limited, Medicamen Biotech Limited, Group Pharmaceuticals Limited, Srini Pharmaceuticals Private Limited, Inject Care Parenterals Private Limited and 2 more, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Sachin Navinchandra Doshi ceased to be Director on 01 Apr 2021. Kaushik Maniar ceased to be Additional Director on 30 Dec 2020. Niraj Anilkumar Mehta ceased to be Additional Director on 30 Dec 2020. DWD Pharmaceuticals has 10 board changes on record in total.
Yes, DWD Pharmaceuticals is registered as a medium enterprise under Udyam registration (number: UDYAM-MH-19-0005833).
DWD Pharmaceuticals has 12 MSME Form 1 returns on record between 2019 and 2024, listing 258 overdue payments to 56 micro and small suppliers. The latest return was filed on 30 Apr 2024.